Publication | Closed Access

Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial

InflammationAsthmaAnti-inflammatoryLung InflammationImmunologyClinical TrialsPulmonary PharmacologyAirway Inflammatory CellsImmunotherapyMedicineModerate-to-severe Uncontrolled AsthmaClinical Allergy